Thrombin generation in hemorrhage control and vascular occlusion.
作者信息
Mann Kenneth G
机构信息
Department of Biochemistry, Colchester Research Facility Room 235, University of Vermont, Colchester, VT 05446, USA.
出版信息
Circulation. 2011 Jul 12;124(2):225-35. doi: 10.1161/CIRCULATIONAHA.110.952648.
Abstract
摘要
相似文献
1
Thrombin generation in hemorrhage control and vascular occlusion.凝血酶生成在出血控制和血管闭塞中的作用。
Circulation. 2011 Jul 12;124(2):225-35. doi: 10.1161/CIRCULATIONAHA.110.952648.
2
Thrombin Generation Assays (TGAs).凝血酶生成测定（TGAs）。
Methods Mol Biol. 2017;1646:515-522. doi: 10.1007/978-1-4939-7196-1_37.
3
Mechanism of action of recombinant activated factor VII: an update.重组活化因子VII的作用机制：最新进展
Semin Hematol. 2006 Jan;43(1 Suppl 1):S105-7. doi: 10.1053/j.seminhematol.2005.11.025.
4
Enzymatically oxidized phospholipids restore thrombin generation in coagulation factor deficiencies.酶氧化磷脂可恢复凝血因子缺乏症中的凝血酶生成。
JCI Insight. 2018 Mar 22;3(6):98459. doi: 10.1172/jci.insight.98459.
5
[Thrombin generation assays and their clinical application].[凝血酶生成检测及其临床应用]
Orv Hetil. 2014 Jun 1;155(22):851-7. doi: 10.1556/OH.2014.29899.
6
Coagulation Profile after Spontaneous Intracerebral Hemorrhage: A Cohort Study.自发性脑出血后的凝血指标：一项队列研究。
J Stroke Cerebrovasc Dis. 2018 Nov;27(11):2951-2961. doi: 10.1016/j.jstrokecerebrovasdis.2018.06.022. Epub 2018 Jul 30.
7
Sample conditions determine the ability of thrombin generation parameters to identify bleeding phenotype in FXI deficiency.样本条件决定了凝血酶生成参数识别 FXI 缺乏症出血表型的能力。
Blood. 2015 Jul 16;126(3):397-405. doi: 10.1182/blood-2014-12-616565. Epub 2015 Apr 24.
8
Blood coagulation: hemostasis and thrombin regulation.血液凝固：止血与凝血酶调节。
Anesth Analg. 2009 May;108(5):1433-46. doi: 10.1213/ane.0b013e31819bcc9c.
9
[Coagulation and fibrinolytic activity of lymph in various pathological conditions (review of own and literature data)].[不同病理状态下淋巴液的凝血和纤溶活性（自身及文献数据综述）]
Patol Fiziol Eksp Ter. 2013 Jan-Mar(1):99-108.
10
Thrombin and protease-activated receptors (PARs) in atherothrombosis.凝血酶与蛋白酶激活受体（PARs）在动脉粥样硬化血栓形成中的作用
Thromb Haemost. 2008 Feb;99(2):305-15. doi: 10.1160/TH07-08-0481.
引用本文的文献
1
Protofibril packing density of individual fibers alters fibrinolysis.单个纤维的原纤维堆积密度会改变纤维蛋白溶解。
Res Pract Thromb Haemost. 2025 Feb 28;9(2):102708. doi: 10.1016/j.rpth.2025.102708. eCollection 2025 Feb.
2
Statins during Anticoagulation for Emergency Life-Threatening Venous Thromboembolism: A Review.他汀类药物在抗凝治疗危及生命的急性静脉血栓栓塞症中的应用：综述。
Medicina (Kaunas). 2024 Jul 30;60(8):1240. doi: 10.3390/medicina60081240.
3
Fibrinolysis biomarker, thrombin, and activated protein C level alterations after coagulation activation depend on type of thrombophilia and clinical phenotype.凝血激活后纤维蛋白溶解生物标志物、凝血酶和活化蛋白C水平的改变取决于血栓形成倾向的类型和临床表型。
Res Pract Thromb Haemost. 2024 Feb 15;8(2):102351. doi: 10.1016/j.rpth.2024.102351. eCollection 2024 Feb.
4
An intelligent DNA nanodevice for precision thrombolysis.一种用于精准溶栓的智能 DNA 纳米器件。
Nat Mater. 2024 Jun;23(6):854-862. doi: 10.1038/s41563-024-01826-y. Epub 2024 Mar 6.
5
Statins Effects on Blood Clotting: A Review.他汀类药物对凝血的影响：综述。
Cells. 2023 Nov 27;12(23):2719. doi: 10.3390/cells12232719.
6
P2Y12 Inhibition Suppresses Proinflammatory Platelet-Monocyte Interactions.P2Y12 抑制可抑制促炎的血小板-单核细胞相互作用。
Thromb Haemost. 2023 Feb;123(2):231-244. doi: 10.1055/s-0042-1758655. Epub 2023 Jan 11.
7
Comparative sequence analysis of vitamin K-dependent coagulation factors.维生素 K 依赖性凝血因子的比较序列分析。
J Thromb Haemost. 2022 Dec;20(12):2837-2849. doi: 10.1111/jth.15897. Epub 2022 Oct 11.
8
Functional Characterization of Antithrombin Mutations by Monitoring of Thrombin Inhibition Kinetics.通过监测凝血酶抑制动力学对抗凝血酶突变进行功能表征。
Int J Mol Sci. 2021 Feb 20;22(4):2119. doi: 10.3390/ijms22042119.
9
Self-regulated hirudin delivery for anticoagulant therapy.自我调节水蛭素递药用于抗凝治疗。
Sci Adv. 2020 Oct 9;6(41). doi: 10.1126/sciadv.abc0382. Print 2020 Oct.
10
Intelligent classification of platelet aggregates by agonist type.根据激动剂类型对血小板聚集物进行智能分类。
Elife. 2020 May 12;9:e52938. doi: 10.7554/eLife.52938.
本文引用的文献
1
Dilutional control of prothrombin activation at physiologically relevant shear rates.在生理相关剪切速率下对凝血酶原激活的稀释控制。
Biophys J. 2011 Feb 2;100(3):765-773. doi: 10.1016/j.bpj.2010.12.3720.
2
The molecular origins of the mechanical properties of fibrin.纤维蛋白力学性能的分子起源。
Biophys Chem. 2010 Nov;152(1-3):15-20. doi: 10.1016/j.bpc.2010.08.009.
3
Cellular regulation of blood coagulation: a model for venous stasis.细胞对血液凝固的调控：静脉淤滞模型。
Blood. 2010 Dec 23;116(26):6082-91. doi: 10.1182/blood-2010-01-266395. Epub 2010 Sep 23.
4
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes.氯吡格雷和阿司匹林在急性冠脉综合征中的剂量比较。
N Engl J Med. 2010 Sep 2;363(10):930-42. doi: 10.1056/NEJMoa0909475.
5
Eptifibatide: The evidence for its role in the management of acute coronary syndromes.依替巴肽：其在急性冠脉综合征管理中作用的证据
Core Evid. 2010 Jun 15;4:49-65. doi: 10.2147/ce.s6008.
6
Biomechanics in hemostasis and thrombosis.止血与血栓形成中的生物力学。
J Thromb Haemost. 2010 May;8(5):1027-9. doi: 10.1111/j.1538-7836.2010.03808.x. Epub 2010 Feb 11.
7
The mechanical properties of single fibrin fibers.单根纤维蛋白纤维的力学性能。
J Thromb Haemost. 2010 May;8(5):1030-6. doi: 10.1111/j.1538-7836.2010.03745.x. Epub 2010 Jan 17.
8
Regulation of cardiomyocyte full-length tissue factor expression and microparticle release under inflammatory conditions in vitro.体外炎症条件下心肌细胞全长组织因子表达及微粒释放的调控
J Thromb Haemost. 2009 May;7(5):871-8. doi: 10.1111/j.1538-7836.2009.03323.x. Epub 2009 Feb 18.
9
Discordant fibrin formation in hemophilia.血友病中纤维蛋白形成不一致
J Thromb Haemost. 2009 May;7(5):825-32. doi: 10.1111/j.1538-7836.2009.03306.x. Epub 2009 Jan 28.
10
Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation.ST段抬高型心肌梗死患者闭塞冠状动脉内促凝组织因子携带微粒水平升高：内皮损伤和白细胞激活的作用
Atherosclerosis. 2009 Jun;204(2):636-41. doi: 10.1016/j.atherosclerosis.2008.10.039. Epub 2008 Nov 12.
Zotero 插件